SciELO - Scientific Electronic Library Online

 
vol.23 número91Irritabilidad y síndrome de WilliamsCOVID-19, contaminación y asma índice de autoresíndice de assuntospesquisa de artigos
Home Pagelista alfabética de periódicos  

Serviços Personalizados

Journal

Artigo

Indicadores

Links relacionados

  • Em processo de indexaçãoCitado por Google
  • Não possue artigos similaresSimilares em SciELO
  • Em processo de indexaçãoSimilares em Google

Compartilhar


Pediatría Atención Primaria

versão impressa ISSN 1139-7632

Resumo

OCHOA-SANGRADOR, Carlos  e  GIMENO-DIAZ-DE ATAURI, Álvaro. Bronchodilators in bronchiolitis: should we reassess their selective use?. Rev Pediatr Aten Primaria [online]. 2021, vol.23, n.91, pp.317-320.  Epub 06-Fev-2023. ISSN 1139-7632.

Authors' conclusions

compared to guidelines‐guided strategy, treating infants with viral bronchiolitis using the phenotypic‐guided bronchodilator therapy strategy is a more cost‐effective strategy, because it involves a lower probability of hospital admission at lower total treatment costs. Randomized controlled trials using biomarkers to stratify patients most likely to respond to bronchodilators are necessary.

Reviewers' commentary

the available information does not seem sufficient to make changes to the current recommendations in acute bronchiolitis management. There is still need for a predictive model that allows to identify potential responders to bronchodilators, as well as a clinical trial with a sufficient sample size to estimate the effectiveness of the strategy of its selective use.

Palavras-chave : Bronchiolitis; Bronchodilators; Costs and cost analysis.

        · resumo em Espanhol     · texto em Espanhol     · Espanhol ( pdf )